An update of phase I data from RTOG 0211: A phase I/II clinical study of ZD 1839 (Gefitinib) plus radiation for newly diagnosed glioblastoma (GBM) patients

被引：0
|
作者：
Chakravarti, A
Seiferheld, W
Robins, HI
Guha, A
Brachman, D
Curran, W
Choucair, A
Mehta, M
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Amer Coll Radiol, Philadelphia, PA USA
[3] Univ Wisconsin, Madison, WI USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Fdn Canc Res, Phoenix, AZ USA
[6] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[7] LDS Hosp, Salt Lake City, UT USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [41] Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme (GBM).
    Shih, Kent C.
    Patel, Manish R.
    Butowski, Nicholas A.
    Bacha, Jeffrey A.
    Brown, Dennis
    Garner, William J.
    Stelno, Anne
    Schwartz, Richard Stephen
    Kanekal, Sarath
    Lopez, Lorena
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] PHASE I/II STUDY OF DIANHYDROGALACTITOL IN PATIENTS WITH RECURRENT MALIGNANT GLIOBLASTOMA MULTIFORME (GBM)
    Shih, Kent
    Patel, Manish
    Butowski, Nicholas
    Bacha, Jeffrey
    Brown, Dennis
    Garner, William
    Steino, Anne
    Schwartz, Richard
    Kanekal, Sarath
    Lopez, Lorena
    Burris, Howard A., III
    NEURO-ONCOLOGY, 2014, 16
  • [43] SYMPTOM BURDEN IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA UNDERGOING RADIOTHERAPY PLUS TEMOZOLOMIDE AND ENZASTAURIN: RESULTS FROM A PHASE I/II TRIAL
    Butowski, Nicholas
    Parvataneni, Rupa
    Nicole, Angelina
    Lamborn, Kathleen
    Polley, Mei
    Clarke, Jennifer
    Chang, Susan
    Page, Margaretta
    Prados, Michael
    Liepa, Astra
    Shi, P.
    Thornton, Donald
    NEURO-ONCOLOGY, 2010, 12 : 104 - 104
  • [44] A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Nghiemphu, Phioanh Leia
    Wen, Patrick Y.
    Lamborn, Kathleen R.
    Drappatz, Jan
    Robins, H. Ian
    Fink, Karen
    Malkin, Mark G.
    Lieberman, Frank S.
    DeAngelis, Lisa M.
    Torres-Trejo, Alejandro
    Chang, Susan M.
    Abrey, Lauren
    Fine, Howard A.
    Demopoulos, Alexis
    Lassman, Andrew B.
    Kesari, Santosh
    Mehta, Minesh P.
    Prados, Michael D.
    Cloughesy, Timothy F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1422 - 1427
  • [45] Phase I study of ruxolitinib with radiation and temozolomide in patients with newly diagnosed grade III gliomas and glioblastoma.
    Rauf, Yasmeen
    Hufsey, Rachel
    Robinson, Kathy
    Suh, John H.
    Chao, Samuel T.
    Murphy, Erin Sennett
    Yu, Jennifer S.
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    Wei, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
  • [47] Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
    Kortmann, Rolf-Dieter
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (10) : 670 - 671
  • [48] Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
    Lai, Albert
    Tran, Anh
    Nghiemphu, Phioanh L.
    Pope, Whitney B.
    Solis, Orestes E.
    Selch, Michael
    Filka, Emese
    Yong, William H.
    Mischel, Paul S.
    Liau, Linda M.
    Phuphanich, Surasak
    Black, Keith
    Peak, Scott
    Green, Richard M.
    Spier, Cynthia E.
    Kolevska, Tatjana
    Polikoff, Jonathan
    Fehrenbacher, Louis
    Elashoff, Robert
    Cloughesy, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 142 - 148
  • [49] PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew D.
    Wong, Eric T.
    Doherty, Lisa M.
    LaFrankie, Debra C.
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Schiff, David
    Batchelor, Tracy T.
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie E.
    Wen, Patrick Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 85 - 90
  • [50] Phase I/II study of enzastaurin (ENZ) plus temozolomide (TMZ) and radiation therapy (XRT) in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS)
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Page, M.
    Rabbitt, J.
    Fedoroff, A.
    Parvataneni, R.
    Nicol, S. J.
    Thornton, D.
    Prados, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345